ASCO GI 2024 | Integration of patient cancer data: AI and machine learning

Raghav Sundar, MD, PhD, National University Cancer Institute, Singapore, Singapore, discusses the exciting era of generating extensive patient cancer data using various technologies. He highlights the need to integrate this wealth of information, including clinical health records, radiology, and pathology images. Dr Sundar emphasizes the potential of artificial intelligence and machine learning algorithms in integrating and analyzing these diverse datasets. The goal is to gain a deeper understanding of cancer biology and enhance the personalization of patient treatments.This interview took place at the 2024 ASCO Gastrointestinal (GI) Cancers Symposium in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.